UnitedHealth Group Incorporated(UNH)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Healthcare Plans
UnitedHealth Group Incorporated logo

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

Latest News & Analysis

UnitedHealth Group (UNH) stock analysis: Navigating Medicare changes and DOJ investigation for investors.
Apr 9, 2025

UnitedHealth (UNH): Medicare Advantage Boost vs. DOJ Investigation

UNH is navigating market opportunities and regulatory challenges. A Medicare Advantage payment hike offers a revenue boost, but a DOJ investigation looms.

Read more →
UnitedHealth Group (UNH) faces DOJ investigation, DEI policy changes, and healthcare utilization pressures affecting stock performance.
Mar 28, 2025

UnitedHealth (UNH): Navigating DOJ Probe, DEI Shifts, and Utilization Pressures

UnitedHealth Group (UNH) faces DOJ scrutiny, DEI policy shifts, rising healthcare utilization, and regulatory changes. Analysis of challenges, financial impact, and market position.

Read more →
UnitedHealth Group analysis: Navigating regulations, innovation, and market dynamics. UNH stock insights and earnings preview.
Mar 24, 2025

UnitedHealth (UNH): DOJ Probe, Earnings, and Future of Healthcare

UnitedHealth Group (UNH) faces regulatory scrutiny and macroeconomic pressures while embracing innovation. Upcoming earnings, DOJ investigation, and Optum Rx's initiatives are key.

Read more →
UnitedHealth Group faces DOJ investigation amid Optum Rx transformation. Analysis of UNH stock performance, regulatory risks, and financial health.
Mar 19, 2025

UnitedHealth Group: DOJ Probe, Optum Rx, and Security Costs

UnitedHealth faces DOJ scrutiny over billing, Optum Rx simplifies prescriptions, and executive security spending rises. Stock shows mixed performance amidst these developments.

Read more →
UnitedHealth Group (UNH) DOJ Investigation: Impact on Stock, Revenue, and Healthcare Security
Mar 17, 2025

UnitedHealth (UNH) Under DOJ Scrutiny: Market Impact Analysis

UnitedHealth Group (UNH) faces a DOJ investigation, fiduciary duty scrutiny, and rising security costs, impacting its stock performance and investor confidence.

Read more →
UnitedHealth stock: DOJ investigation impacts UNH shares. Stay informed on financial risks, growth, and analyst views.
Mar 11, 2025

UnitedHealth (UNH) Under DOJ Investigation: Investor Impact

UnitedHealth Group (UNH) faces a DOJ investigation over billing practices, sparking investor concerns and a fiduciary duty probe. Analysis of potential impacts on UNH stock and financials.

Read more →
UnitedHealth Group (UNH) DOJ Investigation: Investor Analysis of Financial Risks and Market Impact
Mar 10, 2025

UnitedHealth (UNH) Faces DOJ Probe: Investor Impact & Analysis

UnitedHealth Group (UNH) faces a DOJ probe into Medicare billing, sparking investor concerns. Analysis of UNH's market position, financial health, and competitive dynamics.

Read more →
UNH Stock Analysis: Financial performance, legal challenges, and strategic growth initiatives.
Mar 5, 2025

UnitedHealth (UNH) Intraday Update: Legal, Earnings & Strategy

Intraday update on UnitedHealth’s performance, legal rulings, and strategic growth initiatives. Data-driven analysis from verified sources.

Read more →
UnitedHealth Group (UNH) DOJ Investigation: Market Analysis, Stock Volatility, and Future Outlook
Mar 3, 2025

UnitedHealth Group (UNH) Under DOJ Investigation: Market Analysis and Outlook

UnitedHealth Group (UNH) faces a DOJ probe into Medicare billing, sparking market volatility and investor concern. Our analysis dives deep into the allegations and outlook.

Read more →
UnitedHealth Group (UNH) faces DOJ probe, regulatory scrutiny, rising costs impacting UNH stock. Analysis of challenges and future outlook.
Feb 28, 2025

UnitedHealth Group (UNH) Under Scrutiny: DOJ Probe, Regulatory Challenges, and Market Impact

UnitedHealth Group (UNH) faces a DOJ probe, Senator Grassley's inquiry, and rising costs. Analysis of challenges and opportunities for investors.

Read more →
UnitedHealth Group (UNH) Analysis: DOJ Investigation, Medicare Billing, and Market Impact. Stay informed on UNH stock and healthcare sector trends.
Feb 27, 2025

UnitedHealth Group (UNH) Faces DOJ Probe: Market Impact & Analysis

UnitedHealth Group (UNH) faces a DOJ probe, Senator Grassley's inquiry, rising medical costs, and coverage changes, creating market uncertainty. Read our analysis.

Read more →
UnitedHealth Group faces DOJ investigation and senatorial inquiry amid rising medical costs and coverage changes, impacting UNH stock.
Feb 26, 2025

UnitedHealth Group (UNH) Under Fire: DOJ Probe, Rising Costs, and Market Volatility

UnitedHealth Group (UNH) faces a DOJ probe, rising medical costs, and market volatility. This report analyzes the impact on UNH's stock and the healthcare industry.

Read more →
UnitedHealth Group (UNH) stock under DOJ investigation: Market impact and investor analysis.
Feb 25, 2025

UnitedHealth Group (UNH) Under Scrutiny: DOJ Investigation and Market Impact

UnitedHealth Group (UNH) faces a DOJ probe, sparking market volatility. This analysis covers allegations, financial impacts, competition, and the long-term outlook for investors.

Read more →
UnitedHealth Group (UNH) stock plummets amid DOJ investigation. Market volatility and potential oversold conditions.
Feb 24, 2025

UnitedHealth Group Under Scrutiny: DOJ Investigation and Market Volatility

UnitedHealth Group (UNH) faces a DOJ probe into Medicare billing, causing market volatility. Despite this, some analysts see it as oversold. Key takeaways inside.

Read more →
UnitedHealth Group faces DOJ probe amid billing fraud allegations, impacting stock price. Analysis of financial risks and healthcare sector implications.
Feb 21, 2025

UnitedHealth Group Faces Medicare Billing Investigation

UnitedHealth Group faces a DOJ probe into Medicare billing practices amid cyberattacks and executive losses, spurring significant market volatility.

Read more →
Abstract network representing interconnected healthcare data.
Feb 20, 2025

UnitedHealth Group Restructuring and Market Impact: Workforce Reduction and Future Outlook

An in-depth analysis of UnitedHealth Group's recent workforce restructuring, regulatory challenges, and strategic shifts affecting market performance.

Read more →
Seedling emerging from soil, representing growth and potential.
Feb 19, 2025

UnitedHealth Group: Market Impact, Regulatory Challenges, and Future Outlook

A comprehensive intraday analysis of UnitedHealth Group’s market performance, strategic initiatives, and regulatory challenges.

Read more →
UnitedHealth Group logo overlaid on a stock chart, illustrating market performance.
Feb 18, 2025

UNH Navigates Regulatory Headwinds & Market Volatility

An in‐depth analysis of UNH’s stock performance, regulatory setbacks, dividend trends, and growth strategies amid market volatility.

Read more →